Reuterina junior® chewable tablets is a dietary supplement containing the patented lactic acid bacterium Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) Protectis® (L. reuteri DSM 17938) that helps the good microorganisms restore a natural balance in the gut. L. reuteri Protectis® naturally colonizes humans it has a strong adaptation to persist and interact with humans.
Each chewable, strawberry-flavoured tablet contains the same amount of cultures as 5 drops of the liquid Reuterina® drops. Reuterina® chews can be given to children over the age of 2 who are able to chew a tablet. They can be used for all the same conditions for infants and children as Reuterina® drops. Reuterina junior® has been clinically validated, with beneficial effects in a variety of health conditions including:
Constipation
Diarrhoea
Functional
abdominal
pain (FAP)
Antibiotic-associated diarrhoea
Reduce airway infections
Immunity
Children older than 2 years. DURING ANTIBIOTICS: Chew one (1) tablet daily during therapy and for at least 3 days thereafter or as recommended by your healthcare professional.
DAILY USE: Chew one (1) tablet daily or as recommended by your healthcare professional.
Each Reuterina junior® chew tablet contains a minimum of 100 million (1 x 10⁸) live, freeze-dried colony forming units (CFU) Limosilactobacillus reuteri Protectis® (strain DSM 17938) until expiry.
Excipients: Calcium stearate, citric acid, isomalt, strawberry flavouring, xylitol (sweetener).
Children older than 2 years. DURING ANTIBIOTICS: Chew one (1) tablet daily during therapy and for at least 3 days thereafter or as recommended by your healthcare professional.
DAILY USE: Chew one (1) tablet daily or as recommended by your healthcare professional.
Reuterina junior® helps restore and maintain a healthy balance of intestinal flora in children during antibiotic therapy. Your child can chew one Reuterina junior® tablet daily during antibiotic therapy and continue for at least 3 days after therapy has stopped.
Reuterina junior® is also indicated to assist your child in the daily treatment and prevention of conditions linked to an imbalance in their gastrointestinal microflora.
There are no known drug interactions with Reuterina junior® tablets.
Yes. A single dose of Reuterina ® drops (5 ml) is equal to one Reuterina junior® chewable tablet.
Each dose of Reuterina® drops (0.2 ml) (5 drops) contains 100 million live, freeze-dried colony-forming units (CFUs) of Limosilactobacillus reuteri Protectis®. One Reuterina junior® chewable tablet also contains 100 million live, freeze-dried CFUs of L. reuteri Protectis® (strain DSM 17938).
SUITABLE FOR AGES 3+
